These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 16432855)

  • 21. Expression in transgenic mice of dominant interfering Fas mutations: a model for human autoimmune lymphoproliferative syndrome.
    Choi Y; Ramnath VR; Eaton AS; Chen A; Simon-Stoos KL; Kleiner DE; Erikson J; Puck JM
    Clin Immunol; 1999 Oct; 93(1):34-45. PubMed ID: 10497009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unmasking Evans syndrome: T-cell phenotype and apoptotic response reveal autoimmune lymphoproliferative syndrome (ALPS).
    Teachey DT; Manno CS; Axsom KM; Andrews T; Choi JK; Greenbaum BH; McMann JM; Sullivan KE; Travis SF; Grupp SA
    Blood; 2005 Mar; 105(6):2443-8. PubMed ID: 15542578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 18-Fluorodeoxyglucose positron emission tomography does not aid in diagnosis of pancreatic ductal adenocarcinoma.
    Matsumoto I; Shirakawa S; Shinzeki M; Asari S; Goto T; Ajiki T; Fukumoto T; Kitajima K; Ku Y
    Clin Gastroenterol Hepatol; 2013 Jun; 11(6):712-8. PubMed ID: 23353642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FDG PET/MR for the assessment of lymph node involvement in lymphoma: initial results and role of diffusion-weighted MR.
    Platzek I; Beuthien-Baumann B; Ordemann R; Maus J; Schramm G; Kitzler HH; Laniado M; Kotzerke J; van den Hoff J
    Acad Radiol; 2014 Oct; 21(10):1314-9. PubMed ID: 25086953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
    Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
    Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential clinical role of fluorodeoxyglucose-positron emission tomography in assessing primary or secondary lymphomas of the parotid gland.
    Basu S; Mahne A; Iruvuri S; Alavi A
    Clin Lymphoma Myeloma; 2007 Jan; 7(4):309-14. PubMed ID: 17324340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of 18F-FDG positron emission tomography following allogeneic transplantation to guide adoptive immunotherapy with donor lymphocyte infusions.
    Hart DP; Avivi I; Thomson KJ; Peggs KS; Morris EC; Goldstone AH; Linch DC; Ell PJ; Bomanji JB; Mackinnon S
    Br J Haematol; 2005 Mar; 128(6):824-9. PubMed ID: 15755287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FDG-PET/CT findings of autoimmune pancreatitis.
    Kamisawa T; Takum K; Anjiki H; Egawa N; Kurata M; Honda G; Tsuruta K
    Hepatogastroenterology; 2010; 57(99-100):447-50. PubMed ID: 20698206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Value of [18F]fluorodeoxyglucose positron emission tomography in the management of follicular lymphoma: the end of a dilemma?
    Janikova A; Bolcak K; Pavlik T; Mayer J; Kral Z
    Clin Lymphoma Myeloma; 2008 Oct; 8(5):287-93. PubMed ID: 18854283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoimmune lymphoproliferative syndrome: a syndrome associated with inherited genetic defects that impair lymphocytic apoptosis--CT and US features.
    Avila NA; Dwyer AJ; Dale JK; Lopatin UA; Sneller MC; Jaffe ES; Puck JM; Straus SE
    Radiology; 1999 Jul; 212(1):257-63. PubMed ID: 10405750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can full-dose contrast-enhanced CT be omitted from an FDG-PET/CT staging examination in newly diagnosed FDG-avid lymphoma?
    van Hamersvelt HP; Kwee TC; Fijnheer R; Beek FJ; de Klerk JM; Nievelstein RA
    J Comput Assist Tomogr; 2014; 38(4):620-5. PubMed ID: 24681861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoimmune lymphoproliferative syndrome: a cause of chronic splenomegaly, lymphadenopathy, and cytopenias in children-report on diagnosis and management of five patients.
    Alvarado CS; Straus SE; Li S; Dale JK; Mann K; Le A; Lauer SJ
    Pediatr Blood Cancer; 2004 Aug; 43(2):164-9. PubMed ID: 15236285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymph node metastasis of squamous cell carcinoma from an unknown primary in the upper and middle neck: Impact of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography.
    Deron PB; Bonte KM; Vermeersch HF; Van de Wiele C
    Cancer Biother Radiopharm; 2011 Jun; 26(3):331-4. PubMed ID: 21711095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome.
    Straus SE; Sneller M; Lenardo MJ; Puck JM; Strober W
    Ann Intern Med; 1999 Apr; 130(7):591-601. PubMed ID: 10189330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of fluorodeoxyglucose positron-emission tomography with computed tomography for staging of urothelial carcinoma.
    Lodde M; Lacombe L; Friede J; Morin F; Saourine A; Fradet Y
    BJU Int; 2010 Sep; 106(5):658-63. PubMed ID: 20151968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of FDG-PET/CT in the management of lymphoma.
    Baba S; Abe K; Isoda T; Maruoka Y; Sasaki M; Honda H
    Ann Nucl Med; 2011 Dec; 25(10):701-16. PubMed ID: 22037934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PET/CT in the evaluation of lymphoma in patients with HIV-1 with suppressed viral loads.
    Goshen E; Davidson T; Avigdor A; Zwas TS; Levy I
    Clin Nucl Med; 2008 Sep; 33(9):610-4. PubMed ID: 18716509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kimura's disease with generalized lymphadenopathy demonstrated by positron emission tomography scan.
    Wang TF; Liu SH; Kao CH; Chu SC; Kao RH; Li CC
    Intern Med; 2006; 45(12):775-8. PubMed ID: 16847367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical mimics of lymphoma.
    Brown JR; Skarin AT
    Oncologist; 2004; 9(4):406-16. PubMed ID: 15266094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.